MTOR and Insulin resistance: Alternatively, our data point to other potential disease mechanisms, including PA-mediated reduction in mTOR signaling promoting increased cell death (23), and glucosylceramide- and glycosphingolipid-mediated worsening of local insulin resistance and cell death (24).